Candel Therapeutics (CADL)

• Market cap: $312M
• 1 day: 1.43%
• 5 days: -2.57%
• 1 month: -7.34%
• 3 months: 23.21%
• 6 months: -11.25%
• Year to date: 4.41%
• 1 year: -35.6%
• 5 years: -18.86%
• 10 years: -18.86%
• Sector: Healthcare
• Industry: Biotechnology

About: Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.

Employees: 38